SUNPHARMA.BO

Sun Pharmaceutical Industries Limited
BSEINREQUITY Healthcare DELAYED
Last price
1,900.90
▼ 0.10 (0.01%)
MARKET ·

Price

Open
1,919.45
Prev close
1,901.00
Day high
1,919.50
Day low
1,883.45
Volume
29.11K
Market cap
$4.56T
P/E (TTM)
41.78
52W range
1,547.25 – 1,919.50

Insider net activity

6m · Form 4 rollup
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
Net transactions
0
Buys less sells
Sell : buy shares
Not enough filings
Insider-held shares
1.34B
Total on file

Insider transactions

Account required
DateInsiderAction SharesValueHeld
Jan 13, 26
Life Insurance Corporation of India
Institution- Corporation
202.50K Direct
What this is, and what it is not

These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.

A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.

This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.

Free account required

Officer and director trades in their own stock, straight from Form 4 filings.

Insider holders

1 reporting
NameRelationShares heldLatest
Life Insurance Corporation of India
Institution- Corporation 120.08M Acquisition

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Options analytics

Account required
Put / call volume
Put / call open interest
Positioning, not flow
Max pain
ATM implied vol
Nearest strike to spot
Skew (10% OTM)
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
Heaviest put OI

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Options chain

Account required
ExpirySpot 1,900.90
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Fundamentals

TTM · reported
Market cap$4.56T
Enterprise value$3.87T
Revenue (TTM)$568.09B
Gross profit$446.18B
EBITDA$160.25B
Net income$109.15B
EPS (TTM)$45.50
Free cash flow
Total cash$278.80B
Total debt$52.15B
Book value / share$324.46
Shares outstanding2.40B
Float1.07B
Short % of float
Dividend yield0.97%
Beta (5Y)0.10

Valuation & profitability ratios

Account required
Trailing P/E41.78
Forward P/E33.61
PEG ratio
Price / sales
Price / book5.86
EV / revenue6.82
EV / EBITDA24.17
Gross margin78.54%
Operating margin26.17%
Profit margin19.21%
Return on equity
Return on assets
Debt / equity6.68
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 5 quarters
Blank means not reported, not zero
Line item2026202520242023YoY
Total revenue $582.20B$520.41B$477.58B$432.79B +11.9%
Operating revenue $582.20B$520.41B$477.58B$432.79B +11.9%
Cost of revenue $131.73B$121.98B$120.70B$119.42B +8.0%
Gross profit $450.47B$398.44B$356.89B$313.36B +13.1%
Selling, general & admin $114.77B$103.00B$92.17B$80.45B +11.4%
Total operating expense $314.52B$272.63B$252.21B$220.59B +15.4%
Operating income $135.95B$125.81B$104.68B$92.77B +8.1%
Net interest income $5.76B$9.99B$7.84B$2.13B -42.3%
Pre-tax income $151.19B$137.52B$110.88B$94.08B +9.9%
Tax provision $35.54B$27.72B$14.39B$8.48B +28.2%
Net income $114.79B$109.29B$95.76B$84.74B +5.0%
Net income to common $114.79B$109.29B$95.76B$84.74B +5.0%
EBIT $154.58B$139.83B$113.26B$95.80B +10.5%
EBITDA $183.96B$165.59B$138.83B$121.11B +11.1%

Earnings

History & consensus estimates
Reported vs expected · EPS
QuarterEst.ActualSurprise
Dec 2025 12.7315.48 +21.6%
Sep 2025 11.9713.00 +8.6%
Mar 2025 9.919.00 -9.2%
Jun 2025 12.5811.98 -4.8%
Forward consensus
PeriodEPSAnalystsRevenueGrowth
Current quarter 12.73 10 $147.91B +8.2%
Next quarter 12.61 3 $152.56B +10.1%
Current year 50.35 32 $581.13B +10.5%
Next year 56.55 36 $643.52B +10.7%

Analyst targets & ownership

Account required
Mean target$1,963.26
High target$2,450.00
Low target$1,550.00
Implied upside3.28%
Analyst count38
ConsensusBUY
Strong buy / Buy10 / 24
Hold0
Sell / Strong sell2 / 2
Held by insiders55.62%
Held by institutions27.45%
Institutions holding296
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
SMA 20
SMA 50
SMA 100
SMA 200
EMA 12
EMA 26
EMA 50
RSI (14)
MACD (12,26,9)
Hist —
ATR (14)
Realised vol 30D
Annualised
Bollinger upper
20, 2σ
Bollinger lower
20, 2σ
50 / 200 cross
Trend bias

Risk profile

Daily returns · 1Y window
Beta vs SPY
Correlation to SPY
Realised vol 30D
Annualised
Market vol 1Y
SPY, annualised
Max drawdown 1Y
Peak to trough
Max drawdown 5Y
Peak to trough
ATR 14
Average true range
Beta (reported)
0.10
5Y monthly, from filing

Dividends & splits

Declared · from the issuer
Forward rate$16.50 / yr
Forward yield0.97%
5-year avg yield0.94%
Payout ratio35.16%
Ex-dividend dateFeb 5, 2026
Next pay date
Last split2:1
Split dateJul 29, 2013

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.